Liver transplantatation- an overview
- PMID: 24426424
- PMCID: PMC3689386
- DOI: 10.1007/s12262-012-0643-0
Liver transplantatation- an overview
Abstract
Liver transplantation is a therapeutic option of choice for acute and chronic end-stage liver disease. Indications, contraindications, and surgical procedures for the liver transplantation have become well established. In most part of the world, the main source of liver for transplantation remains the donation after brain death (DBD), but in view of increasing death on the waiting list due to shortage of brain dead organs other options such as split liver transplantation, living donor liver transplantation (LDLT), and donation after cardiac death (DCD) have been used. In the pretransplantation era, liver failure was nearly universally fatal, with mortality from fulminant hepatic failure of 80-90 %, and 1-year mortality in decompensated cirrhosis of more than 50 %. In contrast, liver transplantation patient survival is presently more than 85 % at 1 year and more than 70 % at 5 years, emphasizing the clinical benefit of liver transplantation for either acute or chronic liver failure.
Keywords: End-stage liver disease; Liver transplantation; Living donor.
Similar articles
-
Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.J Hepatol. 2017 Nov;67(5):957-965. doi: 10.1016/j.jhep.2017.06.027. Epub 2017 Jul 8. J Hepatol. 2017. PMID: 28690174
-
Survival advantage for patients accepting the offer of a circulatory death liver transplant.J Hepatol. 2019 May;70(5):855-865. doi: 10.1016/j.jhep.2018.12.033. Epub 2019 Jan 11. J Hepatol. 2019. PMID: 30639505
-
Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry.Transplantation. 2014 Jan 15;97 Suppl 1:S1-S27. doi: 10.1097/01.TP.0000438215.16737.68. Transplantation. 2014. PMID: 24356460
-
Living donor liver transplantation.Trop Gastroenterol. 2007 Apr-Jun;28(2):45-50. Trop Gastroenterol. 2007. PMID: 18050838 Review.
-
[Liver transplantation from a living donor: necessity or an alternative?].Ned Tijdschr Geneeskd. 2001 Mar 24;145(12):563-7. Ned Tijdschr Geneeskd. 2001. PMID: 11293994 Review. Dutch.
Cited by
-
Anesthesia Management of Modified Ex Vivo Liver Resection and Autotransplantation.Ann Transplant. 2018 Apr 27;23:274-284. doi: 10.12659/AOT.907796. Ann Transplant. 2018. PMID: 29700275 Free PMC article.
-
Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management.Cancers (Basel). 2023 Oct 24;15(21):5118. doi: 10.3390/cancers15215118. Cancers (Basel). 2023. PMID: 37958294 Free PMC article. Review.
-
In Vitro Generation of Functional Liver Organoid-Like Structures Using Adult Human Cells.PLoS One. 2015 Oct 21;10(10):e0139345. doi: 10.1371/journal.pone.0139345. eCollection 2015. PLoS One. 2015. PMID: 26488607 Free PMC article.
-
Invasive Fungal Infections After Liver Transplantation: A Retrospective Matched Controlled Risk Analysis.Ann Transplant. 2021 Aug 6;26:e930117. doi: 10.12659/AOT.930117. Ann Transplant. 2021. PMID: 34354035 Free PMC article.
-
A Study on iPSC-Associated Factors in the Generation of Hepatocytes.Tissue Eng Regen Med. 2024 Dec;21(8):1245-1254. doi: 10.1007/s13770-024-00674-w. Epub 2024 Nov 4. Tissue Eng Regen Med. 2024. PMID: 39495460
References
-
- Benhamou JP. Fulminant and sub-fulminant hepatic failure: definition and causes. In: Williams R, Hughes RD, editors. Acute liver failure: improved understanding and better therapy. London: Mitre; 1991. pp. 6–10.
-
- O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445. - PubMed
Publication types
LinkOut - more resources
Full Text Sources